Telemedycyna Polska (WAR:TMP) Piotroski F-Score: 6 (As of Aug. 02, 2026) — 50% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:TMP Telemedycyna Polska SA WAR:TMP
28 GF Score
Price zł0.65
GF Value zł0.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Telemedycyna Polska Piotroski F-Score?

Telemedycyna Polska WAR:TMP +1.56% 28 Piotroski F-Score is 6 as of Aug. 02, 2026, which is 50% above its 10-year median of 4.00. GuruFocus rates WAR:TMP with a GF Score™ of 28/100 and a GF Value™ of zł0.82 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 646 Healthcare Providers & Services companies, Telemedycyna Polska ranks better than 75.23% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Telemedycyna Polska has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Telemedycyna Polska's Piotroski F-Score or its related term are showing as below:

WAR:TMP' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 4   Max: 8
Current: 6

During the past 13 years, the highest Piotroski F-Score of Telemedycyna Polska was 8. The lowest was 2. And the median was 4.

Telemedycyna Polska  (WAR:TMP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Telemedycyna Polska Piotroski F-Score Related Terms


Telemedycyna Polska Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Telemedycyna Polska's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telemedycyna Polska Piotroski F-Score Chart

Telemedycyna Polska Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 4.00 4.00 3.00 4.00

Telemedycyna Polska Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 5.00 4.00 6.00

WAR:TMP vs VEEV, BTSG, HQY: Piotroski F-Score Comparison

For the Health Information Services subindustry, Telemedycyna Polska's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telemedycyna Polska Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Telemedycyna Polska's Piotroski F-Score falls into.


WAR:TMP
28GF Score
Telemedycyna Polska SA WAR:TMP
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -0.4 + -0.381 + -0.272 + -0.047 = zł-1.10 Mil.
Cash Flow from Operations was -0.119 + -0.466 + 0.321 + -0.045 = zł-0.31 Mil.
Revenue was 1.259 + 1.368 + 1.339 + 1.425 = zł5.39 Mil.
Gross Profit was 1.167 + 1.26 + 1.243 + 1.292 = zł4.96 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(2.816 + 2.352 + 2.111 + 1.793 + 2.34) / 5 = zł2.2824 Mil.
Total Assets at the begining of this year (Mar25) was zł2.82 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.00 Mil.
Total Current Assets was zł1.57 Mil.
Total Current Liabilities was zł2.21 Mil.
Net Income was -0.63 + -0.65 + -0.834 + -0.413 = zł-2.53 Mil.

Revenue was 1.417 + 1.363 + 1.463 + 1.308 = zł5.55 Mil.
Gross Profit was 1.22 + 1.189 + 1.327 + 1.173 = zł4.91 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(4.82 + 4.128 + 3.452 + 2.409 + 2.816) / 5 = zł3.525 Mil.
Total Assets at the begining of last year (Mar24) was zł4.82 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.00 Mil.
Total Current Assets was zł1.42 Mil.
Total Current Liabilities was zł2.16 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Telemedycyna Polska's current Net Income (TTM) was -1.10. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Telemedycyna Polska's current Cash Flow from Operations (TTM) was -0.31. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-1.1/2.816
=-0.390625

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-2.527/4.82
=-0.52427386

Telemedycyna Polska's return on assets of this year was -0.390625. Telemedycyna Polska's return on assets of last year was -0.52427386. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Telemedycyna Polska's current Net Income (TTM) was -1.10. Telemedycyna Polska's current Cash Flow from Operations (TTM) was -0.31. ==> -0.31 > -1.10 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/2.2824
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/3.525
=0

Telemedycyna Polska's gearing of this year was 0. Telemedycyna Polska's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1.572/2.208
=0.71195652

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1.424/2.158
=0.65987025

Telemedycyna Polska's current ratio of this year was 0.71195652. Telemedycyna Polska's current ratio of last year was 0.65987025. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Telemedycyna Polska's number of shares in issue this year was 13.583. Telemedycyna Polska's number of shares in issue last year was 10.682. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4.962/5.391
=0.92042293

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4.909/5.551
=0.88434516

Telemedycyna Polska's gross margin of this year was 0.92042293. Telemedycyna Polska's gross margin of last year was 0.88434516. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=5.391/2.816
=1.91441761

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=5.551/4.82
=1.15165975

Telemedycyna Polska's asset turnover of this year was 1.91441761. Telemedycyna Polska's asset turnover of last year was 1.15165975. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+1+0+1+1
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Telemedycyna Polska has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 6 mean?
Telemedycyna Polska (WAR:TMP) has a Piotroski F-Score of 6 as of Aug. 02, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Telemedycyna Polska and its competitors. This is 50% above median its historical median of 4.00. Over the past decade, Telemedycyna Polska's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Telemedycyna Polska ranks #160 out of 646 companies in the Healthcare Providers & Services industry, placing it in the top 24.8%.
Is Telemedycyna Polska's Piotroski F-Score too high?
Telemedycyna Polska's current Piotroski F-Score of 6 is 50% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Telemedycyna Polska's value of 6 is 20% above this industry median. Based on the distribution chart, Telemedycyna Polska ranks #160 out of 646 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 28/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Piotroski F-Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #160 out of 646 companies for Piotroski F-Score. This places Telemedycyna Polska in the top 25% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Telemedycyna Polska's value of 6 is 20% above this benchmark. Historically, Telemedycyna Polska's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Telemedycyna Polska has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telemedycyna Polska's current Piotroski F-Score of 6 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current Piotroski F-Score is 6, which is 50% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.82, compared to a current price of zł0.65 — trading 20.7% below its estimated fair value. The current Piotroski F-Score is 6, which is 50% above median its 10-year median of 4.00 and 20% above the Healthcare Providers & Services industry median of 5.00. Telemedycyna Polska's overall GF Score™ is 28/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Piotroski F-Score is 6 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?

Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued. The current stock price of zł0.65 is trading 20.7% below its estimated GF Value™ of zł0.82. GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.

Key valuation signals for WAR:TMP:

  • Piotroski F-Score: 6 (50% above median its 10-year median of 4.00)
  • GF Value™: zł0.82 vs. price of zł0.65 (20.7% below fair value)
  • GF Score™: 28/100 with 5 warning signs
  • Industry Position: 20% above the Healthcare Providers & Services median (#160 of 646)

No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Telemedycyna Polska Business Description

Address Ulica Ligocka 103, Katowice, POL, 40-568
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
28GF Score

Get the complete analysis for WAR:TMP

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.65
Price
zł0.82
GF Value